← Back to Search

Coping Strategies for Chronic Pain

N/A
Recruiting
Led By Dokyoung S You, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Prescription opioid use (>3 months)
Chronic pain ( > 3months)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at day 14 (7 days after intervention)
Awards & highlights

Study Summary

This trial will test whether pain catastrophizing is a possible treatment target to reduce prescription opioid craving.

Who is the study for?
This trial is for adults over 18 with chronic pain lasting more than 3 months who have been using prescription opioids. Participants must speak English and have access to email or a smartphone. People with cancer, severe psychiatric conditions, concurrent psychological therapy, skin conditions on the hand, or without technology access cannot join.Check my eligibility
What is being tested?
The study tests if 'pain catastrophizing'—a negative mental approach to pain—can be reduced to lessen opioid craving in chronic pain patients. It will also explore if stress hormones and negative emotions are part of why this might work.See study design
What are the potential side effects?
Since this intervention involves coping statements rather than medication, traditional side effects like those seen with drugs are not expected. However, participants may experience emotional discomfort when addressing their thoughts about pain.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been using prescribed opioids for more than 3 months.
Select...
I have been experiencing pain for more than 3 months.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at day 14 (7 days after intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and at day 14 (7 days after intervention) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
craving
Secondary outcome measures
Anxiety symptoms
Cortisol
Depression symptoms
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Coping statementExperimental Treatment1 Intervention
Daily practice of pain coping statements for 7 days
Group II: ControlActive Control1 Intervention
No instruction about pain coping statement.

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,470 Previous Clinical Trials
2,619,574 Total Patients Enrolled
55 Trials studying Chronic Pain
82,804 Patients Enrolled for Chronic Pain
Stanford UniversityLead Sponsor
2,395 Previous Clinical Trials
17,341,199 Total Patients Enrolled
36 Trials studying Chronic Pain
9,077 Patients Enrolled for Chronic Pain
Dokyoung S You, PhDPrincipal InvestigatorStanford University

Media Library

Coping Statement Clinical Trial Eligibility Overview. Trial Name: NCT04097743 — N/A
Chronic Pain Research Study Groups: Coping statement, Control
Chronic Pain Clinical Trial 2023: Coping Statement Highlights & Side Effects. Trial Name: NCT04097743 — N/A
Coping Statement 2023 Treatment Timeline for Medical Study. Trial Name: NCT04097743 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the full scope of participants for this research endeavor?

"Affirmative. The information on clinicaltrials.gov confirms that this inquiry is actively recruiting patients, with the trial first posted on June 29th 2021 and recently revised on June 9th 2022. 156 people are needed for enrollment at a single site."

Answered by AI

Are there available vacancies in this clinical experiment?

"As per the information published on clinicaltrials.gov, this study is still in the process of recruiting participants to take part. This trial was made available from June 29th 2021 and has been updated most recently on June 9th 2022."

Answered by AI
~33 spots leftby Jan 2025